TY - STD TI - Society, A.C. American Cancer Society: Key Statistics for Colorectal Cancer. About colorectal cancer. 2019. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html#references. Accessed Feb 21 2018. UR - https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html#references ID - ref1 ER - TY - STD TI - Howlader N, N.A., Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ CK. SEER Cancer Statistics Review. 2016. https://seer.cancer.gov/statfacts/html/colorect.html. Accessed Jan 23 2017 UR - https://seer.cancer.gov/statfacts/html/colorect.html ID - ref2 ER - TY - JOUR AU - Fernald, K. AU - Kurokawa, M. PY - 2013 DA - 2013// TI - Evading apoptosis in cancer JO - Trends Cell Biol VL - 23 UR - https://doi.org/10.1016/j.tcb.2013.07.006 DO - 10.1016/j.tcb.2013.07.006 ID - Fernald2013 ER - TY - JOUR AU - Watson, A. J. PY - 2004 DA - 2004// TI - Apoptosis and colorectal cancer JO - Gut VL - 53 UR - https://doi.org/10.1136/gut.2004.052704 DO - 10.1136/gut.2004.052704 ID - Watson2004 ER - TY - JOUR AU - Abraha, A. M. AU - Ketema, E. B. PY - 2016 DA - 2016// TI - Apoptotic pathways as a therapeutic target for colorectal cancer treatment JO - World J Gastrointest Oncol VL - 8 UR - https://doi.org/10.4251/wjgo.v8.i8.583 DO - 10.4251/wjgo.v8.i8.583 ID - Abraha2016 ER - TY - JOUR AU - Hao, X. PY - 1998 DA - 1998// TI - Imbalance between proliferation and apoptosis in the development of colorectal carcinoma JO - Virchows Arch VL - 433 UR - https://doi.org/10.1007/s004280050284 DO - 10.1007/s004280050284 ID - Hao1998 ER - TY - JOUR AU - Hawkins, N. PY - 1997 DA - 1997// TI - Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia JO - Tumour Biol VL - 18 UR - https://doi.org/10.1159/000218025 DO - 10.1159/000218025 ID - Hawkins1997 ER - TY - JOUR AU - Fulda, S. PY - 2010 DA - 2010// TI - Evasion of apoptosis as a cellular stress response in cancer JO - Int J Cell Biol VL - 2010 ID - Fulda2010 ER - TY - JOUR AU - Jeught, K. PY - 2018 DA - 2018// TI - Drug resistance and new therapies in colorectal cancer JO - World J Gastroenterol VL - 24 UR - https://doi.org/10.3748/wjg.v24.i34.3834 DO - 10.3748/wjg.v24.i34.3834 ID - Jeught2018 ER - TY - JOUR AU - Yin, S. Y. PY - 2013 DA - 2013// TI - Therapeutic applications of herbal medicines for cancer patients JO - Evid Based Complement Alternat Med VL - 2013 ID - Yin2013 ER - TY - JOUR AU - Oka, H. PY - 1995 DA - 1995// TI - Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9) JO - Cancer VL - 76 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Oka1995 ER - TY - JOUR AU - Luk, J. M. PY - 2007 DA - 2007// TI - Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation JO - Liver Int VL - 27 UR - https://doi.org/10.1111/j.1478-3231.2007.01527.x DO - 10.1111/j.1478-3231.2007.01527.x ID - Luk2007 ER - TY - JOUR AU - Lin, F. M. PY - 2007 DA - 2007// TI - Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells JO - Carcinogenesis VL - 28 UR - https://doi.org/10.1093/carcin/bgm137 DO - 10.1093/carcin/bgm137 ID - Lin2007 ER - TY - JOUR AU - Al-Otaibi, J. S. AU - Gogary, T. M. PY - 2017 DA - 2017// TI - Synthesis of novel anthraquinones: molecular structure, molecular chemical reactivity descriptors and interactions with DNA as antibiotic and anti-cancer drugs JO - J Mol Struct VL - 1130 UR - https://doi.org/10.1016/j.molstruc.2016.10.098 DO - 10.1016/j.molstruc.2016.10.098 ID - Al-Otaibi2017 ER - TY - JOUR AU - Duval, J. AU - Pecher, V. AU - Poujol, M. AU - Lesellier, E. PY - 2016 DA - 2016// TI - Research advances for the extraction, analysis and uses of anthraquinones: a review JO - Ind Crop Prod. VL - 94 UR - https://doi.org/10.1016/j.indcrop.2016.09.056 DO - 10.1016/j.indcrop.2016.09.056 ID - Duval2016 ER - TY - JOUR AU - Pandith, S. A. AU - Hussain, A. AU - Bhat, W. W. PY - 2014 DA - 2014// TI - Evaluation of anthraquinones from Himalayan rhubarb (Rheum emodi Wall. ex Meissn.) as antiproliferative agents JO - South Afr J Bot. VL - 95 UR - https://doi.org/10.1016/j.sajb.2014.07.012 DO - 10.1016/j.sajb.2014.07.012 ID - Pandith2014 ER - TY - JOUR AU - Rumie Vittar, N. B. PY - 2014 DA - 2014// TI - Photochemotherapy using natural anthraquinones: Rubiadin and Soranjidiol sensitize human cancer cell to die by apoptosis JO - Photodiagn Photodyn Ther VL - 11 UR - https://doi.org/10.1016/j.pdpdt.2014.02.002 DO - 10.1016/j.pdpdt.2014.02.002 ID - Rumie Vittar2014 ER - TY - JOUR AU - Chen, Z. PY - 2012 DA - 2012// TI - Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPARgamma-agonist activity JO - J Cell Biochem VL - 113 UR - https://doi.org/10.1002/jcb.24232 DO - 10.1002/jcb.24232 ID - Chen2012 ER - TY - JOUR AU - Dong, X. PY - 2016 DA - 2016// TI - Emodin: a review of its pharmacology, toxicity and pharmacokinetics JO - Phytother Res VL - 30 UR - https://doi.org/10.1002/ptr.5631 DO - 10.1002/ptr.5631 ID - Dong2016 ER - TY - JOUR AU - Kwak, H. J. PY - 2006 DA - 2006// TI - Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation JO - Int J Cancer VL - 118 UR - https://doi.org/10.1002/ijc.21641 DO - 10.1002/ijc.21641 ID - Kwak2006 ER - TY - JOUR AU - Chen, Y. C. PY - 2002 DA - 2002// TI - Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production JO - Biochem Pharmacol VL - 64 UR - https://doi.org/10.1016/S0006-2952(02)01386-2 DO - 10.1016/S0006-2952(02)01386-2 ID - Chen2002 ER - TY - JOUR AU - Ma, Y. S. PY - 2012 DA - 2012// TI - Antitumor effects of Emodin on LS1034 human colon cancer cells in vitro and in vivo: roles of apoptotic cell death and LS1034 tumor xenografts model JO - Food Chem Toxicol VL - 50 UR - https://doi.org/10.1016/j.fct.2012.01.033 DO - 10.1016/j.fct.2012.01.033 ID - Ma2012 ER - TY - JOUR AU - Muto, A. PY - 2007 DA - 2007// TI - Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor JO - Mol Cancer Ther VL - 6 UR - https://doi.org/10.1158/1535-7163.MCT-06-0605 DO - 10.1158/1535-7163.MCT-06-0605 ID - Muto2007 ER - TY - JOUR AU - Srinivas, G. AU - Anto, R. J. AU - Srinivas, P. AU - Vidhyalakshmi, S. AU - Senan, V. P. AU - Karunagaran, D. PY - 2003 DA - 2003// TI - Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9 JO - Eur J Pharmacol. VL - 473 UR - https://doi.org/10.1016/S0014-2999(03)01976-9 DO - 10.1016/S0014-2999(03)01976-9 ID - Srinivas2003 ER - TY - JOUR AU - Su, Y. T. PY - 2005 DA - 2005// TI - Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway JO - Biochem Pharmacol VL - 70 UR - https://doi.org/10.1016/j.bcp.2005.04.026 DO - 10.1016/j.bcp.2005.04.026 ID - Su2005 ER - TY - JOUR AU - Wei, W. T. PY - 2013 DA - 2013// TI - The distinct mechanisms of the antitumor activity of Emodin in different types of cancer (Review) JO - Oncol Rep VL - 30 UR - https://doi.org/10.3892/or.2013.2741 DO - 10.3892/or.2013.2741 ID - Wei2013 ER - TY - JOUR AU - Yu, C. X. PY - 2008 DA - 2008// TI - Emodin induces apoptosis in human prostate cancer cell LNCaP JO - Asian J Androl VL - 10 UR - https://doi.org/10.1111/j.1745-7262.2008.00397.x DO - 10.1111/j.1745-7262.2008.00397.x ID - Yu2008 ER - TY - JOUR AU - Cha, T. L. PY - 2015 DA - 2015// TI - Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth JO - Mol Carcinog VL - 54 UR - https://doi.org/10.1002/mc.22084 DO - 10.1002/mc.22084 ID - Cha2015 ER - TY - JOUR PY - 2016 DA - 2016// TI - Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement JO - JAMA VL - 315 UR - https://doi.org/10.1001/jama.2016.5989 DO - 10.1001/jama.2016.5989 ID - ref29 ER - TY - STD TI - International W.C.R.F. World Cancer Research Fund International—Colorectal Cancer Statistics. 2017. http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/colorectal-cancer-statistics. Accessed 23 Jan 2017 UR - http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/colorectal-cancer-statistics ID - ref30 ER - TY - JOUR AU - Krajnovic, T. PY - 2018 DA - 2018// TI - Drug delivery system for Emodin based on mesoporous silica SBA-15 JO - Nanomaterials. VL - 8 UR - https://doi.org/10.3390/nano8050322 DO - 10.3390/nano8050322 ID - Krajnovic2018 ER - TY - JOUR AU - Xing, J. Y. PY - 2015 DA - 2015// TI - Antitumor effects and mechanism of novel emodin rhamnoside derivatives against human cancer cells in vitro JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0144781 DO - 10.1371/journal.pone.0144781 ID - Xing2015 ER - TY - JOUR AU - Vazquez, F. PY - 2000 DA - 2000// TI - Phosphorylation of the PTEN tail regulates protein stability and function JO - Mol Cell Biol VL - 20 UR - https://doi.org/10.1128/MCB.20.14.5010-5018.2000 DO - 10.1128/MCB.20.14.5010-5018.2000 ID - Vazquez2000 ER - TY - JOUR AU - Ma, L. AU - Li, W. PY - 2014 DA - 2014// TI - Emodin inhibits LOVO colorectal cancer cell proliferation via the regulation of the Bcl-2/Bax ratio and cytochrome c JO - Exp Ther Med VL - 8 UR - https://doi.org/10.3892/etm.2014.1900 DO - 10.3892/etm.2014.1900 ID - Ma2014 ER - TY - JOUR AU - Zhao, J. AU - Xu, J. AU - Zhao, J. AU - Zhang, R. PY - 2017 DA - 2017// TI - Inhibitory effect of emodin on human colon cancer SW620 cells and possible mechanism JO - Biomed Res. VL - 28 ID - Zhao2017 ER - TY - JOUR AU - Liu, Z. PY - 2010 DA - 2010// TI - Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines JO - Chin J Cancer VL - 29 UR - https://doi.org/10.5732/cjc.009.10666 DO - 10.5732/cjc.009.10666 ID - Liu2010 ER - TY - JOUR AU - Elmore, S. PY - 2007 DA - 2007// TI - Apoptosis: a review of programmed cell death JO - Toxicol Pathol VL - 35 UR - https://doi.org/10.1080/01926230701320337 DO - 10.1080/01926230701320337 ID - Elmore2007 ER - TY - JOUR AU - Kang, J. PY - 2015 DA - 2015// TI - Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.5763 DO - 10.18632/oncotarget.5763 ID - Kang2015 ER - TY - JOUR AU - Smaili, S. S. PY - 2001 DA - 2001// TI - Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential JO - Cell Death Differ VL - 8 UR - https://doi.org/10.1038/sj.cdd.4400889 DO - 10.1038/sj.cdd.4400889 ID - Smaili2001 ER - TY - JOUR AU - Merino, D. PY - 2009 DA - 2009// TI - The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins JO - J Cell Biol VL - 186 UR - https://doi.org/10.1083/jcb.200905153 DO - 10.1083/jcb.200905153 ID - Merino2009 ER - TY - JOUR AU - Kuo, T. C. PY - 2009 DA - 2009// TI - Emodin has cytotoxic and protective effects in rat C6 glioma cells: roles of Mdr1a and nuclear factor kappaB in cell survival JO - J Pharmacol Exp Ther VL - 330 UR - https://doi.org/10.1124/jpet.109.153007 DO - 10.1124/jpet.109.153007 ID - Kuo2009 ER - TY - JOUR AU - Stephanou, A. AU - Latchman, D. S. PY - 2003 DA - 2003// TI - STAT-1: a novel regulator of apoptosis JO - Int J Exp Pathol VL - 84 UR - https://doi.org/10.1111/j.0959-9673.2003.00363.x DO - 10.1111/j.0959-9673.2003.00363.x ID - Stephanou2003 ER - TY - JOUR AU - McCain, J. PY - 2013 DA - 2013// TI - The MAPK (ERK) Pathway: investigational combinations for the treatment Of BRAF-mutated metastatic melanoma JO - P T VL - 38 ID - McCain2013 ER - TY - JOUR AU - Fornace, A. J. AU - Bulavin, D. V. PY - 2004 DA - 2004// TI - p38 MAP Kinase’s emerging role as a tumor suppressor JO - Adv Cancer Res. VL - 92 UR - https://doi.org/10.1016/S0065-230X(04)92005-2 DO - 10.1016/S0065-230X(04)92005-2 ID - Fornace2004 ER - TY - JOUR AU - Lin, W. PY - 2016 DA - 2016// TI - Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo JO - Oncol Rep VL - 36 UR - https://doi.org/10.3892/or.2016.4861 DO - 10.3892/or.2016.4861 ID - Lin2016 ER - TY - JOUR AU - Cui, Y. PY - 2016 DA - 2016// TI - Involvement of PI3K/Akt, ERK and p38 signaling pathways in Emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis JO - Food Chem Toxicol VL - 92 UR - https://doi.org/10.1016/j.fct.2016.03.013 DO - 10.1016/j.fct.2016.03.013 ID - Cui2016 ER - TY - JOUR AU - Czauderna, F. PY - 2003 DA - 2003// TI - Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA JO - Nucleic Acids Res VL - 31 UR - https://doi.org/10.1093/nar/gkg141 DO - 10.1093/nar/gkg141 ID - Czauderna2003 ER - TY - JOUR AU - Benistant, C. AU - Chapuis, H. AU - Roche, S. PY - 2000 DA - 2000// TI - A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203871 DO - 10.1038/sj.onc.1203871 ID - Benistant2000 ER - TY - JOUR AU - Bian, C. PY - 2018 DA - 2018// TI - PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non-small cell lung cancer JO - Oncol Lett VL - 15 ID - Bian2018 ER - TY - JOUR AU - Catz, S. D. AU - Johnson, J. L. PY - 2001 DA - 2001// TI - Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204926 DO - 10.1038/sj.onc.1204926 ID - Catz2001 ER -